The Yorkshire Lung Screening Trial: Biomarker study content
Detecting lung cancer through screening saves lives.
The Yorkshire Lung Screening Trial (YLST) will test community-based lung cancer screening in mobile vans across Leeds to work out who would most benefit from screening.
The aim is to maximise this valuable opportunity by taking a blood sample when people attend the mobile vans for their scan to look for signs of lung cancer and address the following important questions:
- Can a blood test more accurately determine who should have a scan?
- Can a blood test be used to detect lung cancer earlier?
- Can a blood test improve the performance of scans?
Lead researcher
Professor Matthew Callister
Consultant Respiratory Physician, University of Leeds
Professor Philip Crosbie
Senior Clinical Lecturer & Consultant in Respiratory Medicine, University of Manchester
EPIC-GB – Pioneering brain cancer trials
How can we improve treatment for a brain cancer that hasn’t seen significant breakthroughs in nearly 20…
Improving radiotherapy for lung cancer
Radiotherapy treatment for lung cancer can sometimes damage the heart. Researchers at Leeds Teaching…
Every 15 minutes, someone in Yorkshire is told they have cancer.
Our aim is for more people to survive cancer, here in Yorkshire and beyond.
Please help us continue to fund life-saving research.